LERAVIC
DEAD

Serial Number

88885323

Owner

Tobira Therapeutics, Inc.

Attorney

Cheryl A. Withycombe

Filing Date

Apr 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LERAVIC Trademark

Serial Number: 88885323

LERAVIC is a trademark filed by Tobira Therapeutics, Inc. on April 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tobira Therapeutics, Inc. (8 trademarks)

701 Gateway Blvd, Suite 300
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 23, 2020

Registration Date

Not Registered

Published for Opposition

August 18, 2020

Goods & Services

Pharmaceutical preparations for the treatment and prevention of gastro-intestinal diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 16, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 16, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 12, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 12, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 12, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 12, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 12, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 12, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 13, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2020 CNSA
ASSIGNED TO EXAMINER
Jul 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2020 NWOS
NEW APPLICATION ENTERED
Apr 27, 2020 NWAP